CEO: | James Renwick McCullough |
Chief Technical Officer: | Fergus Fleming |
Non-Executive Chairman: | Christopher H B Mills |
Non-Executive Dir: | Robert (Rob) Graham Naylor, Erik Kristian Lium, Catherine Coste |
Address: | 2 Leman Street, London, United Kingdom, E1W 9US |
Website: | http://www.renalytix.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BYWL4Y04 |
Currency | UK Pounds |
Share Price | 8.75p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 12.50p |
52 Week Low | 5.62p |
Volume | 2,102,454 |
Shares Issued | 437.02m |
Market Cap | £38.24m |
RiskGrade | 348 |
Value | ![]() |
---|
Price Trend | ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:27 | 24,252 @ 8.51p |
16:26 | 15,000 @ 8.51p |
16:24 | 6,000 @ 8.55p |
16:19 | 105,679 @ 8.55p |
16:19 | 117,029 @ 8.55p |
You are here: research